{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:30:33Z","timestamp":1789047033271,"version":"build-2803163510"},"reference-count":217,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>\n                    Skin and soft tissue infections represent a major clinical challenge. This is particularly true given the rise in antimicrobial resistance, the increasing prevalence of chronic wounds, and the growing number of immunocompromised patients. Conventional antibiotic therapies are frequently compromised by multidrug-resistant pathogens, biofilm formation, and disruption of the skin microbiome, underscoring the urgent need for alternative or adjunctive antibacterial strategies. Bacteriophages, viruses that specifically infect and lyse bacteria, have re-emerged as promising therapeutic agents due to their high specificity, activity against antibiotic-resistant strains, and capacity to target biofilm-associated infections. This review provides a comprehensive overview of current advances in bacteriophage-based approaches for the treatment of cutaneous infections and skin disorders. We discuss the biological principles of phage therapy, its advantages and limitations, and the regulatory and manufacturing challenges associated with clinical translation. Particular emphasis is placed on topical and biomaterial-based phage delivery platforms, including hydrogels, nanocarriers, and adhesive wound dressings, designed to enhance phage stability, local bioavailability, and therapeutic efficacy. Furthermore, we summarize experimental and clinical evidence supporting the use of bacteriophages against the most clinically relevant skin pathogens. By integrating data from\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    studies, animal models, clinical trials, and compassionate-use cases, this review highlights both the therapeutic potential and current limitations of phage-based interventions in dermatology. Collectively, the available evidence supports the use of bacteriophages as a viable component of future precision antimicrobial therapies for skin infections, while emphasizing the need for well-designed clinical trials, standardized production protocols, and optimized delivery systems to enable broader clinical adoption.\n                  <\/jats:p>","DOI":"10.1128\/cmr.00048-26","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:00:19Z","timestamp":1781096419000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions"],"prefix":"10.1128","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6018-9371","authenticated-orcid":false,"given":"Emilia","family":"Hauza","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cs8k179","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biotechnology and Food Microbiology, Faculty of Biotechnology and Food Science, Wroc\u0142aw University of Environmental and Life Sciences","place":["Wroc\u0142aw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-341X","authenticated-orcid":false,"given":"Ivy J.","family":"Mutai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04h699437","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Microbiology and Infection, Becky Mayer Centre for Phage Research, University of Leicester","place":["Leicester, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/01htjvr84","id-type":"ROR","asserted-by":"publisher"}],"name":"Antimicrobial Resistance & Bacteriophage Biology Section, Kenya Institute of Primate Research","place":["Karen, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-4077","authenticated-orcid":false,"given":"Agnieszka","family":"Necel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/019sbgd69","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology, Faculty of Medicine, Medical University of Gda\u0144sk","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-0018","authenticated-orcid":false,"given":"Deus","family":"Kamya","sequence":"additional","affiliation":[{"name":"University of East Anglia, Research Park","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/04td3ys19","id-type":"ROR","asserted-by":"publisher"}],"name":"Quadram Institute, Research Park","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/05cs8k179","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Microbial Interactions, Research Park","place":["Norwich, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8453-1591","authenticated-orcid":false,"given":"Paulina","family":"\u015aliwka","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cs8k179","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biotechnology and Food Microbiology, Faculty of Biotechnology and Food Science, Wroc\u0142aw University of Environmental and Life Sciences","place":["Wroc\u0142aw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0778-5031","authenticated-orcid":false,"given":"Izabela","family":"Dusza","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cs8k179","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biotechnology and Food Microbiology, Faculty of Biotechnology and Food Science, Wroc\u0142aw University of Environmental and Life Sciences","place":["Wroc\u0142aw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-2814","authenticated-orcid":false,"given":"Alicja","family":"W\u0119grzyn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011dv8m48","id-type":"ROR","asserted-by":"publisher"}],"name":"Phage Therapy Center, University Center for Applied and Interdisciplinary Research, University of Gda\u0144sk","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6101-472X","authenticated-orcid":true,"given":"Aneta","family":"Skaradzi\u0144ska","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cs8k179","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biotechnology and Food Microbiology, Faculty of Biotechnology and Food Science, Wroc\u0142aw University of Environmental and Life Sciences","place":["Wroc\u0142aw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.04.003"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2020.10.009"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-100422-040919"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.11.005"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/v14061170"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.33073\/pjm-2022-005"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64608-3"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2022.206"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00513"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2024.03.033"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.22207\/JPAM.18.1.49"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2024.01.010"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.154424"},{"key":"e_1_3_3_15_2","unstructured":"Intralytix Inc. 2026. Intralytix Inc.: Bacteriophage Home. Available from: https:\/\/www.intralytix.com\/products"},{"key":"e_1_3_3_16_2","unstructured":"Proteon Pharma. 2021. EFSA Confirms Safety of BAFASAL A \u201cFirst in Class\u201d Innovative Feed Additive. Available from: https:\/\/proteonpharma.com\/efsa-confirms-safety-of-bafasal-a-first-in-class-innovative-feed-additive"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15020588"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa017"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1209782"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01674"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101347"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040751"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1250848"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2562634"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics7010017"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14121285"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01379-14"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13040680"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70280"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020155"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10111277"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00071-17"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.03.010"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106125"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-021-00946-1"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003626"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13553"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36694-8"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9070377"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/20415990.2024.2426824"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules31020324"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8030100"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38318-4"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118779"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120508"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2017.03.029"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00561"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02146-16"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.09.013"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.01.024"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129349"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12718"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2021.1878688"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00453-24"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0147-4"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18147602"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116116"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00411-22"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15020460"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-021-02395-y"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13010007"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00915-24"},{"key":"e_1_3_3_64_2","unstructured":"Centers for Disease Control and Prevention. 2023. HAI Pathogens and Antimicrobial Resistance Report 2018\u20132021. Atlanta GA"},{"key":"e_1_3_3_65_2","unstructured":"European Centre for Disease Prevention and Control and World Health Organization. 2023. Antimicrobial Resistance Surveillance in Europe 2023 - 2021 Data. Stockholm"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051210"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199677"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1374466"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1691-x"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01725"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43141-022-00409-1"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.4c00747"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121085"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15030803"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-024-02106-2"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.3390\/v17010070"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110155"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00565-24"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127662"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01660-4"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134484"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30482-1"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1177\/1534734619835115"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060776"},{"key":"e_1_3_3_85_2","volume-title":"Streptococcus pyogenes","author":"Kanwal S","year":"2023","unstructured":"Kanwal S, Vaitla P. 2023. Streptococcus pyogenes. StatPearls Publishing, Treasure Island (FL)."},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-022-04718-y"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70267-X"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104609"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168177"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0059-2018"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205995"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-021-00141-8"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00358-18"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-12-3-484"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13040612"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-024-03897-6"},{"key":"e_1_3_3_97_2","unstructured":"Bacteriophage News Human Health: Bacteriophage News. 2025. Phagex products for human health. Available from: https:\/\/www.bacteriophage.news\/database\/phagex"},{"key":"e_1_3_3_98_2","unstructured":"Microgen. 2022. Macrogen products; streptophage Streptococcus bacteriophage. Available from: https:\/\/www.microgen.ru\/en\/products\/bakteriofagi\/bakteriofag-streptokokkovyy"},{"key":"e_1_3_3_99_2","unstructured":"Eliava BioPreparations. 2025. Pyo Bacteriophage. Available from: https:\/\/eliava-institute.org"},{"key":"e_1_3_3_100_2","unstructured":"Biochimpharm. 2025. Biochimpharm Official Website. Available from: https:\/\/biochimpharm.ge\/en"},{"issue":"355","key":"e_1_3_3_101_2","first-page":"206","article-title":"Small but mighty: characterization of vB_Spy_7, a lytic phage targeting Streptococcus pyogenes","author":"Rigvava S","year":"2024","unstructured":"Rigvava S, Kusradze I, Karumidze N, Chichashvili M, Tchgkonia I, Goderdzishvili M. 2024. Small but mighty: characterization of vB_Spy_7, a lytic phage targeting Streptococcus pyogenes. Georgian Med News, no. 355:206\u2013210.","journal-title":"Georgian Med News"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01451.x"},{"key":"e_1_3_3_103_2","unstructured":"Biochimpharm. 2025. Septaphage Product Information. Available from: https:\/\/biochimpharm.ge"},{"key":"e_1_3_3_104_2","unstructured":"Micromir. 2025. Phagoderm Gel Product Description. Available from: https:\/\/micromir.ru"},{"key":"e_1_3_3_105_2","unstructured":"Hirszfeld Institute of Immunology and Experimental Therapy. 2025. Phage Therapy Unit. Available from: https:\/\/www.iitd.pan.wroc.pl\/en\/phage-therapy"},{"key":"e_1_3_3_106_2","unstructured":"Phyla (Phi Therapeutics Inc.). 2022. Phortify Probiotic Serum Clinical Study. Available from: https:\/\/www.phyla.com"},{"key":"e_1_3_3_107_2","unstructured":"Ellis Day Skin Science (SmartPhage Inc.). 2022. Balancing Phage Serum Product Data. Available from: https:\/\/www.ellisday.com"},{"key":"e_1_3_3_108_2","unstructured":"BiomX Ltd. 2021. BX001 Clinical Program Results. Available from: https:\/\/www.biomx.com"},{"key":"e_1_3_3_109_2","unstructured":"Aumed a.s. 2023. PhageGlow product line. Available from: https:\/\/aumed.cz\/en\/phageglow"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.877995"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179245"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2439509"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67824"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.18502\/ijm.v13i5.7435"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02620-w"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112048"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01145-24"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2024.01.018"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.0909.09010"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.748718"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091048"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-475x.2001.00066.x"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63754-6"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073790"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27656-z"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1286-4579(03)00049-2"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310537"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020380"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000658"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa210"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.17744"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2022.31.5.436"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37728"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.3390\/gels10080493"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2009.18.6.42801"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02092-22"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0017-2013"},{"key":"e_1_3_3_138_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02772-0"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00234-20"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.ESP-0009-2017"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.3390\/v14061309"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01024"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1128\/MRA.01312-19"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092141"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-019-04305-x"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2018.08.008"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2024.100230"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9102172"},{"key":"e_1_3_3_149_2","unstructured":"Assay M. 2025. MBEC Assay Kit PROCEDURAL MANUAL For High-Throughput Antimicrobial Susceptibility Testing of Biofilms Version 2.4 For use with the following product codes"},{"key":"e_1_3_3_150_2","unstructured":"MTTB. 2025. Mikroliz therapeutic bacteriophage bank (MTBB) is established in Turkey which currently has over 1500 phages against mainly ESKAPE. Available from: https:\/\/bacteriophagebank.com\/pages\/about-us"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615439"},{"key":"e_1_3_3_152_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3280"},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy245"},{"key":"e_1_3_3_154_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01301-0"},{"key":"e_1_3_3_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2023.06.009"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-022-00293-2"},{"key":"e_1_3_3_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.11.018"},{"key":"e_1_3_3_158_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-023-02037-4"},{"key":"e_1_3_3_159_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53317-4"},{"key":"e_1_3_3_160_2","doi-asserted-by":"publisher","DOI":"10.22092\/ARI.2022.359032.2357"},{"key":"e_1_3_3_161_2","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2016.25.Sup7.S27"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics7040087"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.1089\/phage.2020.0010"},{"key":"e_1_3_3_164_2","doi-asserted-by":"publisher","DOI":"10.1177\/1534734619881076"},{"key":"e_1_3_3_165_2","unstructured":"ClinicalTrials.gov. 2006. A prospective randomized double-blind controlled study of WPP-201 for the safety and efficacy of treatment of venous leg ulcers (WPP-201). Available from: https:\/\/clinicaltrials.gov\/study\/NCT00663091"},{"key":"e_1_3_3_166_2","unstructured":"ClinicalTrials.gov. 2021. Bacteriophage therapy TP-102 in diabetic foot ulcers (REVERSE). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04803708"},{"key":"e_1_3_3_167_2","unstructured":"ClinicalTrials.gov. 2026. Standard treatment associated with phage therapy versus placebo for diabetic foot ulcers infected by S. aureus (PhagoPied). Available from: https:\/\/clinicaltrials.gov\/study\/NCT02664740"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.907314"},{"key":"e_1_3_3_169_2","unstructured":"ClinicalTrials.gov. 2021. Phage therapy for the prevention and treatment of wound infections in burned patients. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04323475"},{"key":"e_1_3_3_170_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123997"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00092-13"},{"key":"e_1_3_3_172_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/705741"},{"key":"e_1_3_3_173_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1424849"},{"key":"e_1_3_3_174_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02838-23"},{"key":"e_1_3_3_175_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam7928"},{"key":"e_1_3_3_176_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092222"},{"key":"e_1_3_3_177_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71542"},{"key":"e_1_3_3_178_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01783"},{"key":"e_1_3_3_179_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19922-x"},{"key":"e_1_3_3_180_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46555-7"},{"key":"e_1_3_3_181_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051202"},{"key":"e_1_3_3_182_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032695"},{"key":"e_1_3_3_183_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13090870"},{"key":"e_1_3_3_184_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100656"},{"key":"e_1_3_3_185_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.11.004"},{"key":"e_1_3_3_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.05.017"},{"key":"e_1_3_3_187_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.145371"},{"key":"e_1_3_3_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2015.10.004"},{"key":"e_1_3_3_189_2","doi-asserted-by":"publisher","DOI":"10.3390\/nano10101944"},{"key":"e_1_3_3_190_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0741-x"},{"key":"e_1_3_3_191_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_3_192_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1290296"},{"key":"e_1_3_3_193_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18105479"},{"key":"e_1_3_3_194_2","doi-asserted-by":"publisher","DOI":"10.1109\/ACCESS.2020.3014701"},{"key":"e_1_3_3_195_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01805-y"},{"key":"e_1_3_3_196_2","first-page":"3991","article-title":"Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models","volume":"24","author":"Dabrowska K","year":"2004","unstructured":"Dabrowska K, Opolski A, Wietrzyk J, Switala-Jelen K, Godlewska J, Boratynski J, Syper D, Weber-Dabrowska B, Gorski A. 2004. Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models. Anticancer Res 24:3991\u20133995.","journal-title":"Anticancer Res"},{"key":"e_1_3_3_197_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-9-13"},{"key":"e_1_3_3_198_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601576"},{"key":"e_1_3_3_199_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.12.9.2699"},{"key":"e_1_3_3_200_2","first-page":"241","article-title":"Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway","volume":"48","author":"Dabrowska K","year":"2004","unstructured":"Dabrowska K, Opolski A, Wietrzyk J, Switala-Jelen K, Boratynski J, Nasulewicz A, Lipinska L, Chybicka A, Kujawa M, Zabel M, et al.. 2004. Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway. Acta Virol 48:241\u2013248.","journal-title":"Acta Virol"},{"key":"e_1_3_3_201_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189485"},{"key":"e_1_3_3_202_2","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10142"},{"key":"e_1_3_3_203_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010402"},{"key":"e_1_3_3_204_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.4001944"},{"key":"e_1_3_3_205_2","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-023-01118-8"},{"key":"e_1_3_3_206_2","doi-asserted-by":"publisher","DOI":"10.3390\/v17070975"},{"key":"e_1_3_3_207_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.697876"},{"key":"e_1_3_3_208_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2024.08.506"},{"key":"e_1_3_3_209_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03332-0"},{"key":"e_1_3_3_210_2","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2025.1571857"},{"key":"e_1_3_3_211_2","doi-asserted-by":"publisher","DOI":"10.1038\/380364a0"},{"key":"e_1_3_3_212_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0501"},{"key":"e_1_3_3_213_2","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408086"},{"key":"e_1_3_3_214_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004035"},{"key":"e_1_3_3_215_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.3c00173"},{"key":"e_1_3_3_216_2","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2023.2252667"},{"key":"e_1_3_3_217_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02910-y"},{"key":"e_1_3_3_218_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.3c00382"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00048-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00048-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:02:36Z","timestamp":1789045356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00048-26"}},"subtitle":[],"editor":[{"given":"Jorge","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":217,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9,10]]}},"alternative-id":["10.1128\/cmr.00048-26"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00048-26","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"2026-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00048-26"}}